Lovesac Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

The Lovesac Company will report fiscal third-quarter results before the open on Dec. 11, with analysts forecasting a loss of $0.46 per share versus a $0.01 loss a year ago and consensus revenue of $154.17 million (up from $149.91 million a year earlier). The company added Wan Ling Martello to its board on Nov. 20 and shares slipped 1.5% to $13.74; sell-side coverage remains largely positive, with maintained Buy/Outperform ratings and price targets spanning roughly $24–$35 (notable updates include Maxim’s cut to $33 and Roth MKM’s raise to $28), signaling analyst-perceived upside despite the expected quarterly loss.

Analysis

Lovesac will report fiscal third-quarter results before the open on Dec. 11 with analysts forecasting a loss of $0.46 per share versus a $0.01 loss a year ago and consensus revenue of $154.17 million compared with $149.91 million in the prior-year quarter (≈2.8% top-line growth). The combination of a wider expected loss alongside modest revenue growth suggests margin compression or higher operating costs are driving the deterioration in profitability rather than a collapse in demand.

The company added Wan Ling Martello to its board on Nov. 20, a governance move investors may view as strategic reinforcement ahead of the print. Shares fell 1.5% to $13.74 on Wednesday and the article signals a mildly negative market sentiment, indicating limited investor conviction into the print.

Sell-side coverage remains mostly constructive with maintained Buy/Outperform ratings and price targets clustered between $24 and $35 (notable changes include Maxim trimming a target to $33 from $38 and Roth MKM raising its target to $28 from $22), implying analysts see meaningful upside from current levels despite the expected near-term loss. The immediate market catalyst is the Q3 EPS, revenue and management guidance; a miss would likely reinforce the cautious stance while a beat and positive outlook could prompt re-rating toward those targets.

Key Decisions for Investors

• Monitor the Dec. 11 Q3 release closely for EPS versus the -$0.46 estimate and revenue versus $154.17 million; prioritize margin commentary and guidance as the decisive inputs for near-term direction
• Given the $13.74 share price versus analyst targets of $24–$35, consider only selective, size-constrained accumulation after evidence of improving margins or constructive guidance, and employ stop-losses or hedges to limit downside
• Track any strategic or governance implications from Wan Ling Martello's board appointment and avoid adding meaningful exposure into the print absent clear operational improvement